10 weeks, without any adverse events related to these treatments. Regular dressings were performed at outpatient facilities using potassium permanganate solution 1:10 000 and mupirocine cream then covered with surgical cotton bandages, until the lesions were completely cured.
Cryptotoccus neoformans is a very ubiquitous human pathogen, and the main sources of infection are excrement from pigeons or other birds, as well as decomposing wood, fruit, and vegetables [1, 2] . The most frequent infections are pulmonary cryptococcosis and cryptococcal meningitis [2, 3] , although cases of endocarditis, pyelonephritis, arthritis, osteomyelitis, and prostatitis have been described [1, 4] . Primary cutaneous cryptococcosis (PCC) is a rare condition only recognized since 2003 1-5. It usually presents as a single infiltrative lesion limited to the skin and the subcutaneous cellular tissue without evidence of systemic dissemination [1] [2] [3] [4] [5] . Clinical diagnosis is difficult due to its nonspecific presentation: a single infiltrative lesion resembling cellulitis, herpetic whitlow, subcutaneous nodules, and/or ulceration. There is a notably higher prevalence of serotype D and a much better prognosis compared with the disseminated cryptococcosis [2, 3] . The treatment of cryptococcosis is well covered in the Infectious Diseases Society of America (IDSA) Guidelines of 2010.
In our case, the clinical picture of localized subacute cellulitis, absence of fever, histopathological findings, negative extension study, and the excellent response to treatment led to the diagnosis of PCC. Cellular immunosuppression is a well known risk that was present in our patient. The positive result of the crypto-latex test on peripheral blood cells may be explained by the large extent of the cutaneous infection. The patient lives in an urban area where the contact with birds, including large numbers of pigeons, is very common.
CONCLUSIONS
In conclusion, we describe a new case of PCC in an inmunocompromised patient treated successfully following the latest IDSA guidelines. Differential diagnosis of clinically compatible lesions, which do not respond to antibiotic treatment, must be included. It is vitally important to rule out disseminated infection and establish adequate antifungal treatment.
